Abstract
Obesity is one of the major causes of the development of metabolic diseases, particularly cardiovascular diseases and type-2 diabetes mellitus. Increased lipid accumulation and abnormal adipocyte growth, which is an increase in cell numbers and differentiation, have been documented as major pathological characteristics of obesity. Thus, the inhibition of adipogenic differentiation prevents and suppresses obesity. Recently, specific probiotic strains have been known to regulate lipid metabolism in vitro and/or in vivo. Previously, we demonstrated that Lactobacillus johnsonni 3121 and Lactobacillus rhamnosus 86 could act as novel probiotic strains and reduce cholesterol levels. Moreover, both strains significantly reduced lipid accumulation and inhibited adipocyte differentiation by downregulating the adipogenic transcription factor in 3T3-L1 adipocytes. Therefore, L. johnsonni 3121 and L. rhamnosus 86 were selected for in vivo evaluation of their anti-obesity effects using a high-fat diet-induced obese mouse model. Daily oral administration of L. johnsonni 3121 and L. rhamnosus 86 for 12 weeks significantly improved serum lipid profile and downregulated the expression of genes related to adipogenesis and lipogenesis in epididymal white adipose tissue of high-fat diet fed obese mice (p < 0.05). Fecal analysis also suggested that the two probiotic strains could normalize the altered obesity–related gut microbiota in high-fat diet–fed obese mice. These results collectively demonstrate that oral administration of L. johnsonni 3121 and L. rhamnosus 86 could prevent obesity, thereby improving metabolic health.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Ballini A, Scacco S, Boccellino M, Santacroce L, Arrigoni R (2020) Microbiota and obesity: where are we now? Biol 9(12):415. https://doi.org/10.3390/biology9120415
Diotallevi C, Fava F, Gobbetti M, Tuohy K (2020) Healthy dietary patterns to reduce obesity-related metabolic disease: polyphenol-microbiome interactions unifying health effects across geography. Curr Nutr Metab Care 23(6):437–444. https://doi.org/10.1097/MCO.0000000000000697
Alberti KGMM, Zimmet P, Shaw J (2005) The metabolic syndrome—a new worldwide definition. Lancet 366(9491):1059–1062. https://doi.org/10.1016/s0140-6736(05)67402-8
Camp HS, Ren D, Leff T (2002) Adipogenesis and fat-cell function in obesity and diabetes. Trends Mol Med 8(9):442–447. https://doi.org/10.1016/S1471-4914(02)02396-1
Caricilli AM, Saad MJA (2014) Gut microbiota composition and its effects on obesity and insulin resistance. Curr Opin Clin Nutr Metab Care 17(4):312–318. https://doi.org/10.1097/MCO.0000000000000067
Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Human gut microbes associated with obesity. Nat 444(7122):1022–1023. https://doi.org/10.1038/4441022a
Backhed F, Crawford PA (2010) Coordinated regulation of the metabolome and lipidome at the host-microbial interface. Biochim Biophys Acta 1801(3):240–245. https://doi.org/10.1016/j.bbalip.2009.09.009
Turnbaugh PJ, Backhed F, Fulton L, Gordon JI (2008) Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3(4):213–223. https://doi.org/10.1016/j.chom.2008.02.015
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nat 444(7122):1027–1031. https://doi.org/10.1038/nature05414
Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, Derrien M, Druesne A, Van Hylckama Vlieg JE, Bloks VW, Groen AK, Heilig HG, Zoetendal EG, Stroes ES, de Vos WM, Hoekstra JB, Nieuwdorp M (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterol 143(4):913–916 e917. https://doi.org/10.1053/j.gastro.2012.06.031
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11(8):506–514. https://doi.org/10.1038/nrgastro.2014.66
Delzenne NM, Neyrinck AM, Backhed F, Cani PD (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7(11):639–646. https://doi.org/10.1038/nrendo.2011.126
Abenavoli L, Scarpellini E, Colica C, Boccuto L, Salehi B, Sharifi-Rad J, Aiello V, Romano B, De Lorenzo A, Izzo AA, Capasso R (2019) Gut microbiota and obesity: a role for probiotics. Nutr 11(11):2690. https://doi.org/10.3390/nu11112690
Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y (2005) Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 24(4):257–265. https://doi.org/10.1080/07315724.2005.10719473
Park YH, Kim JG, Shin YW, Kim SH, Whang KY (2007) Effect of dietary inclusion of Lactobacillus acidophilus ATCC 43121 on cholesterol metabolism in rats. J Microbiol Biotechnol 17(4):655–662
Rafter J (2004) The effects of probiotics on colon cancer development. Nutr Res Rev 17(2):277–284. https://doi.org/10.1079/NRR200484
Baken KA, Ezendam J, Gremmer ER, de Klerk A, Pennings JL, Matthee B, Peijnenburg AA, van Loveren H (2006) Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression. Int J Food Microbiol 112(1):8–18. https://doi.org/10.1016/j.ijfoodmicro.2006.06.009
Sato M, Uzu K, Yoshida T, Hamad EM, Kawakami H, Matsuyama H, Abd El-Gawad IA, Imaizumi K (2008) Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 99(5):1013–1017. https://doi.org/10.1017/S0007114507839006
Adams CA (2010) The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev 23(1):37–46. https://doi.org/10.1017/S0954422410000090
Damodharan K, Lee YS, Palaniyandi SA, Yang SH, Suh JW (2015) Preliminary probiotic and technological characterization of Pediococcus pentosaceus strain KID7 and in vivo assessment of its cholesterol-lowering activity. Front Microbiol 6:768. https://doi.org/10.3389/fmicb.2015.00768
Tsujino K, Li JT, Tsukui T, Ren X, Bakiri L, Wagner E, Sheppard D (2017) Fra-2 negatively regulates postnatal alveolar septation by modulating myofibroblast function. Am J Physiol Lung Cell Mol Physiol 313(5):L878–L888. https://doi.org/10.1152/ajplung.00062.2017
Yang F, Zhou L, Song J, WangJinMei A, Yang Y, Tang ZW, Huang QY (2019) Liver CEBPβ modulates the kynurenine metabolism and mediates the motility for hypoxia-induced central fatigue in mice. Front Physiol 10:243. https://doi.org/10.3389/fphys.2019.00243
Park E, Lee CG, Jeong H, Yeo S, Kim JA, Jeong SY (2020) Antiadipogenic effects of mixtures of Cornus officinalis and Ribes fasciculatum extracts on 3T3-L1 preadipocytes and high-fat diet-induced mice. Mol 25(10):2350. https://doi.org/10.3390/molecules25102350
Noh HL, Okajima K, Molkentin JD, Homma S, Goldberg IJ (2006) Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction. Am J Physiol Endocrinol Metab 291(4):E755-760. https://doi.org/10.1152/ajpendo.00111.2006
Kinugawa K, Monnet Y, Lu L, Bekaert AJ, Thery C, Mallat Z, Hirsch EC, Hunot S (2013) MFGE8 does not orchestrate clearance of apoptotic neurons in a mouse model of Parkinson’s disease. Neurobiol Dis 51:192–201. https://doi.org/10.1016/j.nbd.2012.11.010
Li J, Ding L, Song B, Xiao X, Qi M, Yang Q, Yang Q, Tang X, Wang Z, Yang L (2016) Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway. Eur J Pharmacol 770:99–109. https://doi.org/10.1016/j.ejphar.2015.11.045
Fukumitsu S, Aida K, Ueno N, Ozawa S, Takahashi Y, Kobori M (2008) Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. Br J Nutr 100(3):669–676. https://doi.org/10.1017/S0007114508911570
Morrison CJ, Butler GS, Bigg HF, Roberts CR, Soloway PD, Overall CM (2001) Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J Biol Chem 276(50):47402–47410. https://doi.org/10.1074/jbc.M108643200
Schneeberger M, Everard A, Gomez-Valades AG, Matamoros S, Ramirez S, Delzenne NM, Gomis R, Claret M, Cani PD (2015) Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep 5:16643. https://doi.org/10.1038/srep16643
Lee CS, Tan PL, Eor JY, Choi DH, Park M, Seo SK, Yoon S, Yang S, Kim SH (2019) Prophylactic use of probiotic chocolate modulates intestinal physiological functions in constipated rats. J Sci Food Agric 99(6):3045–3056. https://doi.org/10.1002/jsfa.9518
Hardwick SA, Stokes HW, Findlay S, Taylor M, Gillings MR (2008) Quantification of class 1 integron abundance in natural environments using real-time quantitative PCR. FEMS Microbiol Lett 278(2):207–212. https://doi.org/10.1111/j.1574-6968.2007.00992.x
Rokholm B, Baker JL, Sorensen TI (2010) The levelling off of the obesity epidemic since the year 1999-a review of evidence and perspectives. Obes Rev 11(12):835–846. https://doi.org/10.1111/j.1467-789X.2010.00810.x
Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissen M, Taskinen MR, Groop L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24(4):683–689. https://doi.org/10.2337/diacare.24.4.683
Kang JH, Yun SI, Park MH, Park JH, Jeong SY, Park HO (2013) Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS One 8(1):e54617. https://doi.org/10.1371/journal.pone.0054617
Aronsson L, Huang Y, Parini P, Korach-Andre M, Hakansson J, Gustafsson JA, Pettersson S, Arulampalam V, Rafter J (2010) Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 5(9). https://doi.org/10.1371/journal.pone.0013087
Bjerg AT, Kristensen M, Ritz C, Holst JJ, Rasmussen C, Leser TD, Wellejus A, Astrup A (2014) Lactobacillus paracasei subsp paracasei L. casei W8 suppresses energy intake acutely. Appetite 82:111–118. https://doi.org/10.1016/j.appet.2014.07.016
Gutierrez DA, Puglisi MJ, Hasty AH (2009) Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia. Curr Diabetes Rep 9(1):26–32. https://doi.org/10.1007/s11892-009-0006-9
Preiss D, Sattar N (2009) Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clin Endocrinol (Oxf) 70(6):815–828. https://doi.org/10.1111/j.1365-2265.2008.03490.x
Carr SS, Hooper AJ, Sullivan DR, Burnett JR (2019) Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment. Pathology 51(2):148–154. https://doi.org/10.1016/j.pathol.2018.11.006
Kwon J, Kim B, Lee C, Joung H, Kim BK, Choi IS, Hyun CK (2020) Comprehensive amelioration of high-fat diet-induced metabolic dysfunctions through activation of the PGC-1α pathway by probiotics treatment in mice. PLoS One 15(2):e0228932. https://doi.org/10.1371/journal.pone.0228932
Kim B, Kwon J, Kim MS, Park H, Ji Y, Holzapfel W, Hyun CK (2018) Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice. PLoS One 13(12):e0210120. https://doi.org/10.1371/journal.pone.0210120
Liang X, Zhang Z, Zhou X, Lu Y, Li R, Yu Z, Tong L, Gong P, Yi H, Liu T, Zhang L (2020) Probiotics improved hyperlipidemia in mice induced by a high cholesterol diet via downregulating FXR. Food Funct 11(11):9903–9911. https://doi.org/10.1039/d0fo02255a
Siersbaek R, Nielsen R, Mandrup S (2010) PPARγ in adipocyte differentiation and metabolism-novel insights from genome-wide studies. FEBS Lett 584(15):3242–3249. https://doi.org/10.1016/j.febslet.2010.06.010
Semple RK, Chatterjee VK, O’Rahilly S (2006) PPARγ and human metabolic disease. J Clin Invest 116(3):581–589. https://doi.org/10.1172/JCI28003
Linhart HG, Ishimura-Oka K, DeMayo F, Kibe T, Repka D, Poindexter B, Bick RJ, Darlington GJ (2001) C/EBPα is required for differentiation of white, but not brown, adipose tissue. Proc Natl Acad Sci 98(22):12532–12537. https://doi.org/10.1073/pnas.211416898
Wu CW, Chu ES, Lam CN, Cheng AS, Lee CW, Wong VW, Sung JJ, Yu J (2010) PPARγ is essential for protection against nonalcoholic steatohepatitis. Gene Ther 17(6):790–798. https://doi.org/10.1038/gt.2010.41
Jang WY, Bae KB, Kim SH, Yu DH, Kim HJ, Ji YR, Park SJ, Park SJ, Kang MC, Jeong JI, Park SJ, Lee SG, Lee I, Kim MO, Yoon D, Ryoo ZY (2014) Overexpression of Jazf1 reduces body weight gain and regulates lipid metabolism in high fat diet. Biochem Biophys Res Commun 444(3):296–301. https://doi.org/10.1016/j.bbrc.2013.12.094
Tiraby C, Tavernier G, Capel F, Mairal A, Crampes F, Rami J, Pujol C, Boutin J, Langin D (2007) Resistance to high-fat-diet-induced obesity and sexual dimorphism in the metabolic responses of transgenic mice with moderate uncoupling protein 3 overexpression in glycolytic skeletal muscles. Diabetologia 50(10):2190–2199. https://doi.org/10.1007/s00125-007-0765-2
Chen N, Bezzina R, Hinch E, Lewandowski PA, Cameron-Smith D, Mathai ML, Jois M, Sinclair AJ, Begg DP, Wark JD (2009) Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr Res 29(11):784–793. https://doi.org/10.1016/j.nutres.2009.10.003
Ricquier D, Bouillaud F (2000) The uncoupling protein homologues: UCP1, UCP2, UCP3. StUCP AtUCP Biochem J 345(2):161–179. https://doi.org/10.1042/bj3450161
Bratlie M, Hagen IV, Helland A, Erchinger F, Midttun Ø, Ueland PM, Rosenlund G, Sveier H, Mellgren G, Hausken T, Gudbrandsen OQ (2020) Effects of high intake of cod or salmon on gut microbiota profile, faecal output and serum concentrations of lipids and bile acids in overweight adults: a randomised clinical trial. Eur J Nutr 2020:1–18. https://doi.org/10.1007/s00394-020-02417-8
Cani PD, Delzenne NM (2009) The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 15(13):1546–1558. https://doi.org/10.2174/138161209788168164
Dewulf EM, Cani PD, Neyrinck AM, Possemiers S, Van Holle A, Muccioli GG, Deldicque L, Bindels LB, Pachikian BD, Sohet FM, Mignolet E, Francaux M, Larondelle Y, Delzenne NM (2011) Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem 22(8):712–722. https://doi.org/10.1016/j.jnutbio.2010.05.009
Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313–323. https://doi.org/10.1038/nri2515
Neyrinck AM, Possemiers S, Druart C, Van de Wiele T, De Backer F, Cani PD, Larondelle Y, Delzenne NM (2011) Prebiotic effects of wheat arabinoxylan related to the increase in Bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One 6(6):e20944. https://doi.org/10.1371/journal.pone.0020944
Eyupoglu ND, Ergunay K, Acikgoz A, Akyon Y, Yilmaz E, Yildiz BO (2020) Gut microbiota and oral contraceptive use in overweight and obese patients with polycystic ovary syndrome. J Clin Endocrinol Metab 105(12):e4792–e4800. https://doi.org/10.1210/clinem/dgaa600
Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci 110(22):9066–9071. https://doi.org/10.1073/pnas.1219451110
Shen W, Shen M, Zhao X, Zhu H, Yang Y, Lu S, Tan Y, Li G, Li M, Wang J, Hu F, Le S (2017) Anti-obesity effect of capsaicin in mice fed with high-fat diet is associated with an increase in population of the gut bacterium Akkermansia muciniphila Front Microbiol 8:272. https://doi.org/10.3389/fmicb.2017.00272
Truchado P, Gil MI, Suslow T, Allende A (2018) Impact of chlorine dioxide disinfection of irrigation water on the epiphytic bacterial community of baby spinach and underlying soil. PLoS One 13(7):e0199291. https://doi.org/10.1371/journal.pone.0199291
Alard J, Lehrter V, Rhimi M, Mangin I, Peucelle V, Abraham A-E, Mariadassou M, Maguin E, Waligora-Dupriet A-J, Pot B, Wolowczuk I, Grangette C (2016) Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environ Microbiol 18(5):1484–1497. https://doi.org/10.1111/1462-2920.13181
Funding
This work was financially supported by grants funded by the Chong Kun Dang Bio and Korea University Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
All procedures used in these experiments were approved by the Korea University Institutional Animal Care & Use Committee, South Korea (KUIACUC-2016-154).
Conflict of Interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lee, C.S., Park, M.H., Kim, B.K. et al. Antiobesity Effect of Novel Probiotic Strains in a Mouse Model of High-Fat Diet–Induced Obesity. Probiotics & Antimicro. Prot. 13, 1054–1067 (2021). https://doi.org/10.1007/s12602-021-09752-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12602-021-09752-0